We are pleased to provide details of our publically available publications, case studies and other downloads. These include:
Laverty H, Occleston N, Jones R, Little J, Johnson M, Fairlamb D. Effects of transforming growth factor beta 3 in a clinically relevant model of full thickness incisional wounding in the Gottingen mini-pig. Wound Rep Reg 2008;16:A29.
Occleston NL, Fairlamb D, Hutchison J, O'Kane S, Ferguson MW. Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area. Expert Opin Investig Drugs 2009 Aug;18(8):1231-9.
Fairlamb D, Knock A, Mason T, Ludlow L and Ferguson M. The optimal trial design and endpoints for the assessment of scarring. Abstract presented at Scar Club 2010, Montpellier, France.
Renovo Limited, AH Ledwith, MWJ Ferguson, S O’Kane, D Fairlamb and T Mason: UK Patent GB2457965: Methods and systems for determining efficacy of medicaments.
Case Studies & Project Benefits:
Fairlamb D: Case Analysis: Strategic Regulatory Plans. Nov 2013
Fairamb D: Case Analysis: Medical Device Clinical Evaluation Reports. Dec 2013